Roche’s Avastin Delays Tumor Growth in Ovarian Cancer

Roche Holding AG’s cancer treatment Avastin helped extend the length of time before ovarian tumors worsened in a study of patients whose disease had returned after chemotherapy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.